About
Feel Therapeutics is pioneering the application of AI-enabled Digital Precision Medicine to transform how mental health conditions are diagnosed, managed, and treated. Drawing inspiration from objective measurement tools that have revolutionized physical medicine—such as glucometers and heart rate monitors—Feel Therapeutics brings the same rigor to mental healthcare. Their platform continuously collects physiological, digital, and clinical data from wearables, mobile phones, digital health apps, and clinician dashboards around the clock. Proprietary AI algorithms process this data to compute validated biomarkers and metrics across dimensions like mood, stress, sleep, psychomotor activity, and cognitive functioning. Key products include Feel 360º for comprehensive mental health monitoring, Feel RxPal for patient support, and Feel DTx, a precision digital therapeutic program shown in published studies to improve outcomes in depression, anxiety, and ADHD. The platform achieves up to 87% precision in detecting emotional state changes in individuals with depression and anxiety. Feel Therapeutics is designed for healthcare providers, pharmaceutical companies, and clinical researchers looking to integrate objective, continuous mental health data into care pathways and clinical trials. By moving from point-of-care to point-of-need, the platform enables real-time, personalized interventions at scale—making it a powerful tool for advancing evidence-based mental healthcare.
Key Features
- Continuous 24/7 Biometric Monitoring: Collects physiological, digital, and clinical data round-the-clock from wearables, smartphones, health apps, and clinician dashboards.
- AI-Powered Biomarker Computation: Proprietary algorithms compute validated mental health markers for mood, stress, sleep, psychomotor activity, and cognitive functioning from raw sensor data.
- Precision Digital Therapeutics (Feel DTx): Evidence-based, personalized digital therapeutic programs for depression, anxiety, and ADHD—clinically validated in peer-reviewed publications.
- Patient Support & Wellness Programs (Feel RxPal): Real-time, adaptive patient support interventions delivered at the point of need, bridging clinical visits with continuous care.
- Clinical Research & Publications: Backed by published research in journals like Nature Digital Medicine, with patents and validated accuracy of up to 87% in emotional state detection.
Use Cases
- Healthcare providers using continuous biometric monitoring to track patient mental health between clinical visits and adjust treatment plans in real time.
- Pharmaceutical companies integrating Feel's biomarker platform into clinical trials to obtain objective, passive digital endpoints for mental health drug efficacy studies.
- Digital health companies embedding Feel's AI algorithms and biomarker APIs into their own mental wellness applications.
- Employers and health plans deploying Feel's wellness programs to support employee mental health and reduce burnout through personalized, data-driven interventions.
- Clinical researchers studying psychophysiological correlates of stress, mood, and cognitive functioning using Feel's validated biomarker framework.
Pros
- Objective, Passive Data Collection: Eliminates reliance on subjective self-reports by passively gathering physiological and digital signals, reducing patient burden and improving data quality.
- Clinically Validated Outcomes: Published in peer-reviewed journals demonstrating real-world improvements in depression, anxiety, and ADHD—providing credibility for clinical and enterprise adoption.
- End-to-End Platform: Covers the full pipeline from data collection and biomarker computation to therapeutic intervention, enabling seamless integration into healthcare workflows.
Cons
- Requires Wearable Hardware: Full functionality depends on compatible wearable devices, which may increase cost and adoption barriers for some patients or healthcare systems.
- Enterprise-Focused Pricing: The platform is primarily designed for healthcare providers, pharma, and clinical researchers—not accessible as a direct-to-consumer product.
- Limited Publicly Available Pricing: No transparent pricing is listed publicly, requiring prospective customers to contact the company, which can slow evaluation and onboarding.
Frequently Asked Questions
Feel Therapeutics is a Digital Precision Medicine company that uses AI, wearables, and digital biomarkers to objectively monitor and support mental health conditions like depression, anxiety, ADHD, and stress.
The platform continuously collects data from wearables, smartphones, digital health apps, and clinician dashboards 24/7, then processes it using proprietary AI algorithms to generate validated mental health biomarkers.
The platform supports a range of mental health conditions including depression, anxiety, ADHD, and stress, with clinically validated digital therapeutic programs for each.
The platform is designed for healthcare providers, pharmaceutical companies, and clinical researchers seeking to integrate continuous, objective mental health monitoring into care pathways or clinical trials.
Yes. Feel Therapeutics has published research in journals including Nature Digital Medicine, demonstrating up to 87% precision in emotional state detection and superior improvement in depression, anxiety, and ADHD outcomes compared to standard care.